Loading insider details...
Beta
Latest Form 4 (Feb 4, 2026): Grant/Award of 170,000 FULC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 4, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 170,000 | n/a |
| Dec 17, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Sale | 3,452 | $44.6K |
| Jan 28, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 225,000 | n/a |
| Sep 25, 2024 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/Award | 30,000 | n/a |
| Jan 31, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 150,000 | n/a |
| Jul 5, 2023 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/Award | 100,000 | n/a |
| Apr 28, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 127,500 | n/a |
| Feb 13, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 150,000 | n/a |
| Aug 11, 2022 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 50,000 | n/a |
| Jan 21, 2022 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 60,000 | n/a |